Tag Archives: Fatal
Class I Recall Issued for Brainlab Cranial IGS System

The U.S. Food and Drug Administration (FDA) has puts its most serious Class I label on a recall of Brainlab’s Image-Guided Surgery (IGS) System. According to an FDA recall notification, the system was recalled due to potential inaccuracy. Class I … Continue reading
Study Finds Elevated Risk of Leukemia with Long-Term Low-Dose Radiation

High doses of ionizing radiation, such as that released by atomic bombs, are a known cause of leukemia. A new long-term study published in The Lancet Haematology has looked at the rates of leukemia with low-doses of radiation long-term. Researchers … Continue reading
Pedestrian Killed after being Hit by Car in Bayshore

A woman walking across 5th avenue in Bay Shore was fatally struck by a car Tuesday night. Newsday reports that the 66-year-old victim was hit by a 2000 Nissan Maxima headed southbound at 8:47 p.m. A physician assistant from the … Continue reading
Woman Dies After Taking Diet Pill Tainted with DNP

The tragic death of a 21-year-old college student in the U.K. highlights the dangers of buying quick-fix weight loss products online.
Continue reading
FDA Says Diabetes Drug Onglyza May be Linked to Higher Death Rate

After conducting a preliminary review of data, the U.S. Food and Drug Administration (FDA) has issued a report indicating that AstraZeneca’s diabetes drug Onglyza may be linked with an increased rate of death. According to Reuters, an FDA advisory panel … Continue reading
FDA Slow to Warn About Dietary Supplement Dangers

A newly published study is critical of the Food and Drug Administration (FDA) for being slow to take action against weight-loss and dietary supplements that contain chemical ingredients that pose health risks to supplement takers. Though the FDA determined two … Continue reading
Middle-aged Dronedarone Users Have Higher Risk of Hospitalization

New study results reveal that patients age 61 and younger treated with the heart rhythm drug dronedarone (Multaq) have a higher risk for hospitalization than those with treated other anti-arrhythmic drugs. The study, published in Circulation: Cardiovascular Quality and Outcomes, … Continue reading
Will FDA Ban Powdered Caffeine?

The U.S. Food and Drug Administration (FDA) has seldom used its authority to ban supplements from the market, but some regulatory experts say the agency should implement that power for powdered caffeine, which has been linked to at least two … Continue reading
FDA Strengthens Warning Label on Feraheme

The U.S. Food and Drug Administration (FDA) is strengthening an existing warning on the anemia drug Feraheme (ferumoxytol) to reduce the risk of serious, potentially fatal allergic reactions. According to an FDA Safety Announcement dated March 30th, the agency has … Continue reading
Food and Drug Administration Issues Response to Petition for Removal of Essure Birth Control from Market

Last week the Food and Drug Administration (FDA) responded to a petition demanding removal of Essure permanent birth control device from the market. The petition was signed by more than 2,100 women who are concerned about injuries and adverse effects … Continue reading